US Stock MarketDetailed Quotes
TRIB Trinity Biotech
- 1.6000
- -0.0300-1.84%
Close Sep 13 16:00 ET
- 1.6700
- +0.0700+4.38%
Post 18:47 ET
15.14MMarket Cap-580P/E (TTM)
1.6800High1.5800Low129.89KVolume1.5800Open1.6300Pre Close211.12KTurnover2.71%Turnover RatioLossP/E (Static)9.47MShares3.950052wk High-0.52P/B7.67MFloat Cap1.490052wk Low--Dividend TTM4.79MShs Float143.4487Historical High--Div YieldTTM6.14%Amplitude1.4900Historical Low1.6250Avg Price1Lot Size
Trinity Biotech Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.08%-1.1M | -3.72%-2.82M | -1,154.83%-11.56M | -86.78%242K | -789.94%-4.66M | -128.67%-4.42M | -82.05%-2.72M | -106.96%-921K | -57.71%1.83M | -60.16%676K |
| Net income from continuing operations | -12.84%-6.76M | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M | -777.14%-8.95M |
| Operating gains losses | 104.46%571K | -83.15%-163K | -16,764.86%-12.48M | 532.58%385K | -75.46%40K | -6,609.95%-12.82M | -311.90%-89K | 70.63%-74K | 68.88%-89K | 61.39%163K |
| Depreciation and amortization | -68.39%153K | 14.78%691K | -23.83%1.78M | -30.84%462K | -69.22%229K | 85.44%484K | -8.79%602K | -14.98%2.33M | 78.61%668K | -4.12%744K |
| Deferred tax | 50.94%-131K | 709.09%67K | 69.27%-59K | 80.00%-3K | 7,300.00%222K | -820.69%-267K | 92.67%-11K | -14.97%-192K | 98.73%-15K | -98.80%3K |
| Other non cash items | -24.76%2.78M | -97.84%56K | -58.97%10.14M | 153.73%1.1M | -55.28%2.75M | -60.24%3.7M | -77.09%2.59M | 4,336.45%24.71M | -188.93%-2.05M | 2,023.13%6.15M |
| Change In working capital | 229.37%1.67M | -57.11%-2.14M | -107.02%-402K | -49.41%4.58M | -1,620.92%-2.33M | 41.63%-1.29M | -8.00%-1.36M | 3,430.81%5.73M | 209.01%9.06M | 108.61%153K |
| -Change in receivables | ---- | ---- | 208.39%1.05M | ---- | ---- | ---- | ---- | -115.49%-966K | ---- | ---- |
| -Change in inventory | ---- | ---- | -10.72%-971K | ---- | ---- | ---- | ---- | 80.10%-877K | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -1,629.83%-2.77M | ---- | ---- | ---- | ---- | 102.38%181K | ---- | ---- |
| -Change in other working capital | ---- | ---- | -69.00%2.29M | ---- | ---- | ---- | ---- | 32.24%7.39M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 75.08%-1.1M | -3.72%-2.82M | -1,154.83%-11.56M | -86.78%242K | -789.94%-4.66M | -128.67%-4.42M | -82.05%-2.72M | -106.96%-921K | -57.71%1.83M | -60.16%676K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -111.37%-3.17M | -950.64%-13.96M | 514.19%24.76M | 21.64%-891K | 33.08%-886K | 1,647.03%27.86M | 22.51%-1.33M | 31.23%-5.98M | 54.06%-1.14M | 32.41%-1.32M |
| Net PPE purchase and sale | 52.32%-72K | 75.91%-66K | 27.07%-803K | 47.37%-250K | 60.12%-128K | -5.59%-151K | -69.14%-274K | 39.24%-1.1M | 16.67%-475K | -17.58%-321K |
| Net intangibles purchase and sale | -649.39%-3.1M | -293.52%-1.4M | 61.01%-1.9M | 3.17%-641K | 50.95%-492K | 75.09%-413K | 77.14%-355K | 29.12%-4.88M | 65.25%-662K | 40.51%-1M |
| Net business purchase and sale | --0 | ---12.5M | --28.16M | --0 | ---266K | --28.43M | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | ---700K | --0 | --0 | --0 | ---700K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -111.37%-3.17M | -950.64%-13.96M | 514.19%24.76M | 21.64%-891K | 33.08%-886K | 1,647.03%27.86M | 22.51%-1.33M | 31.23%-5.98M | 54.06%-1.14M | 32.41%-1.32M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 129.11%3.92M | 1,072.01%18.85M | -30.19%-16.04M | -25.66%-1.76M | -2.49%-2.43M | -410.93%-13.45M | 112.49%1.61M | -104.72%-12.32M | 60.89%-1.4M | -226.72%-2.37M |
| Net issuance payments of debt | 155.42%5.9M | 396.47%21.12M | 69.30%-7.37M | 7.35%-555K | 16.52%-571K | 30.13%-10.64M | 156.83%4.25M | -1,942.47%-24M | 19.16%-599K | 5.79%-684K |
| Net common stock issuance | --0 | ---- | --0 | --0 | --0 | --0 | ---- | --25.34M | --317K | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---270K | 81.68%-1.05M | --0 | ---- | 74.07%-905K | ---- | -577.24%-5.74M | --63K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 129.11%3.92M | 1,072.01%18.85M | -30.19%-16.04M | -25.66%-1.76M | -2.49%-2.43M | -410.93%-13.45M | 112.49%1.61M | -104.72%-12.32M | 60.89%-1.4M | -226.72%-2.37M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.08%5.78M | -43.89%3.69M | -74.61%6.58M | -13.69%6.26M | 36.11%14.23M | -58.52%4.15M | -74.61%6.58M | -5.19%25.91M | -73.60%7.25M | -63.47%10.45M |
| Current changes in cash | -103.51%-351K | 184.62%2.06M | 85.21%-2.84M | -240.20%-2.41M | -164.27%-7.98M | 1,581.82%9.99M | 84.83%-2.44M | -1,205.71%-19.22M | 59.06%-709K | -205.67%-3.02M |
| Effect of exchange rate changes | -227.06%-108K | 50.00%21K | 60.71%-44K | -578.79%-158K | 107.82%14K | 155.56%85K | -92.31%14K | -303.64%-112K | -80.24%33K | -16.23%-179K |
| End cash Position | -62.63%5.32M | 39.08%5.78M | -43.89%3.69M | -43.89%3.69M | -13.69%6.26M | 36.11%14.23M | -58.52%4.15M | -74.61%6.58M | -74.61%6.58M | -73.60%7.25M |
| Free cash flow | 14.33%-4.27M | -27.94%-4.28M | -106.74%-14.26M | -193.52%-649K | -715.43%-5.28M | -33.46%-4.98M | -4.33%-3.35M | -251.70%-6.9M | -62.59%694K | -147.33%-648K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data